{"id":910,"date":"2019-11-26T08:02:06","date_gmt":"2019-11-26T07:02:06","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=910"},"modified":"2021-10-06T22:39:44","modified_gmt":"2021-10-06T20:39:44","slug":"777777-2","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/777777-2\/","title":{"rendered":"Constituci\u00f3 de Comit\u00e8"},"content":{"rendered":"<p style=\"text-align: right\">22 de Novembre de 2019<\/p>\n<p style=\"text-align: center\"><strong><span style=\"color: #993300;font-size: 18pt\">Comunicat conjunt del Comit\u00e8<\/span><\/strong><\/p>\n<p style=\"text-align: center\"><strong><span style=\"color: #993300;font-size: 18pt\">Constituci\u00f3 del Comit\u00e8<\/span><\/strong><\/p>\n<p>Avui 22 de novembre s&#8217;ha celebrat la primera reuni\u00f3 del primer Comit\u00e8 electe de Dose Innova.<\/p>\n<p>En aquesta reuni\u00f3 s&#8217;ha decidit per consens, prenent com a criteri els resultats de les \u00faltimes eleccions, que la Presid\u00e8ncia i la Secretaria del Comit\u00e8 quedin d&#8217;aquesta forma:<\/p>\n<ul>\n<li>President CCOO &#8211; Andreu Mu\u00f1oz<\/li>\n<li>Secretario USOC &#8211; David Herrero<\/li>\n<\/ul>\n<p>Tamb\u00e9 s&#8217;ha decidit el repartiment dels delegats de Prevenci\u00f3:<\/p>\n<ul>\n<li>CCOO: 1 Delegat de Prevenci\u00f3<\/li>\n<li>USOC: 1 Delegat de Prevenci\u00f3<\/li>\n<li>UGT: 1 Delegat de Prevenci\u00f3<\/li>\n<li>CGT: 1 Delegat de Prevenci\u00f3<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Durant els pr\u00f2xims dies es decidir\u00e0 quines persones formaran part de les diferents Comissions de Treball, una vegada fet, publicarem l&#8217;organigrama del nou Comit\u00e8.<\/p>\n<p>A m\u00e9s, en aquesta primera reuni\u00f3 s&#8217;ha reclamat amb car\u00e0cter urgent una reuni\u00f3 amb RRHH per a actualitzar la informaci\u00f3 del proc\u00e9s de venda de Gen\u00e8rics, aix\u00ed com tractar reclamacions pendents de l&#8217;anterior mandat, tals com el minvament de la quantia econ\u00f2mica de l&#8217;ultim lot de Nadal, la supressi\u00f3 del pagament dels km en hores extres, o el fet de l\u2019\u00faltim d\u00eda laboral de l\u2019any recuperar la jornada de 4 hores.    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>22 de Novembre de 2019 Comunicat conjunt del Comit\u00e8 Constituci\u00f3 del Comit\u00e8 Avui 22 de novembre s&#8217;ha celebrat la primera reuni\u00f3 del primer Comit\u00e8 electe de Dose Innova. En aquesta &#8230; <a title=\"Constituci\u00f3 de Comit\u00e8\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/777777-2\/\" aria-label=\"Leer m\u00e1s sobre Constituci\u00f3 de Comit\u00e8\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":694,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25,26],"tags":[],"class_list":["post-910","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notesinformatives","category-notesinformatives_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=910"}],"version-history":[{"count":1,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/910\/revisions"}],"predecessor-version":[{"id":4751,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/910\/revisions\/4751"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/694"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}